HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

E-selectin targeting to visualize tumors in vivo.

Abstract
Generally angiogenic factors induce the expression of E-selectin in vascular endothelial cells in the tumors. In this study, we employed an anti-E-selectin monoclonal antibody to target tumors in vivo and evaluated an optical imaging reagent to visualize tumor regions. The anti-E-selectin antibody was conjugated on the surface of liposomes, which encapsulated the near-infrared fluorescent substances Cy3 or Cy5.5. The liposomes efficiently recognized human umbilical vein endothelial cells only when E-selectin was induced by angiogenic factors such as TNF-alpha in vitro. Cy5.5 encapsulated into liposomes that were conjugated with an anti-E-selectin antibody successfully visualized Ehrlich ascites tumor cells when transplanted into mice. Thus, E-selectin targeting with liposomes containing a near-infrared fluorescent dye was found effective in visualizing tumors in vivo. This strategy should be extremely useful as a method to identify sentinel lymphatic nodes and angiogenic tumors as well as use for drug delivery to tumor cells.
AuthorsMasahiko Hirai, Yoshie Hiramatsu, Shinki Iwashita, Takayuki Otani, Ling Chen, Yue-guang Li, Masashi Okada, Kazunori Oie, Koich Igarashi, Hideaki Wakita, Masaharu Seno
JournalContrast media & molecular imaging (Contrast Media Mol Imaging) 2010 Mar-Apr Vol. 5 Issue 2 Pg. 70-7 ISSN: 1555-4317 [Electronic] England
PMID20235150 (Publication Type: Journal Article)
Copyright2010 John Wiley & Sons, Ltd.
Chemical References
  • Antibodies, Monoclonal
  • E-Selectin
  • Immunoconjugates
  • Liposomes
Topics
  • Animals
  • Antibodies, Monoclonal
  • Carcinoma, Ehrlich Tumor (diagnosis)
  • E-Selectin (immunology)
  • Endothelial Cells (cytology)
  • Endothelium, Vascular
  • Humans
  • Immunoconjugates
  • Liposomes
  • Mice
  • Neoplasms (diagnosis, pathology)
  • Neovascularization, Pathologic (diagnosis)
  • Umbilical Veins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: